Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-1,540
Closed -$227K – 206
2025
Q1
$227K Sell
1,540
-108
-7% -$16.5K 0.07% 189
2024
Q4
$268K Sell
1,648
-1,728
-51% -$283K 0.07% 176
2024
Q3
$550K Sell
3,376
-73
-2% -$10.8K 0.16% 112
2024
Q2
$471K Buy
3,449
+145
+4% +$20.1K 0.14% 121
2024
Q1
$506K Buy
3,304
+44
+1% +$6.57K 0.15% 114
2023
Q4
$465K Buy
3,260
+369
+13% +$49.2K 0.15% 114
2023
Q3
$379K Buy
2,891
+286
+11% +$43.5K 0.13% 123
2023
Q2
$414K Buy
2,605
+234
+10% +$37.7K 0.14% 107
2023
Q1
$375K Sell
2,371
-48
-2% -$7.2K 0.13% 115
2022
Q4
$339K Buy
2,419
+65
+3% +$9.23K 0.13% 125
2022
Q3
$302K Buy
+2,354
New +$340K 0.14% 122

Other funds holding CLX

Apeiron RIA's CLX Position: Q2 2025 in Review

Apeiron RIA sold out of Clorox (CLX) in Q2 2025, closing a stake of 1,540 shares — an estimated $227K sold.

Apeiron RIA first reported a position in CLX in Q3 2022 and held it in 11 quarters. The position peaked at $550K in Q3 2024. 1,126 funds tracked by Wall St. Rank hold CLX as of Q2 2025.

  • Apeiron RIA reported no remaining Clorox position as of Q2 2025 after selling out during the quarter.
  • Apeiron RIA sold 1,540 Clorox shares in Q2 2025, an estimated $227K.
  • Apeiron RIA first reported a position in Clorox in Q3 2022 and held it in 11 quarters.
  • Apeiron RIA's Clorox position peaked at $550K in Q3 2024.
  • 1,126 funds tracked by Wall St. Rank held Clorox as of Q2 2025.

Based on Apeiron RIA's 13F filing for Q2 2025, filed 7 Aug 2025.